Clean Yield Group Sells 268 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Clean Yield Group reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 12.7% in the 4th quarter, Holdings Channel reports. The firm owned 1,834 shares of the healthcare conglomerate’s stock after selling 268 shares during the period. Clean Yield Group’s holdings in UnitedHealth Group were worth $928,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Delta Financial Group Inc. raised its stake in UnitedHealth Group by 1.0% during the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after purchasing an additional 17 shares during the last quarter. First PREMIER Bank increased its holdings in UnitedHealth Group by 7.0% in the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock valued at $160,000 after buying an additional 18 shares during the period. Genesee Capital Advisors LLC raised its holdings in shares of UnitedHealth Group by 1.9% in the 3rd quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock worth $579,000 after buying an additional 18 shares in the last quarter. Jmac Enterprises LLC raised its stake in UnitedHealth Group by 2.2% during the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after acquiring an additional 18 shares in the last quarter. Finally, Matrix Private Capital Group LLC lifted its holdings in UnitedHealth Group by 3.6% during the 2nd quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 19 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 4.4 %

Shares of NYSE:UNH traded up $23.17 during trading on Monday, hitting $543.86. 4,259,962 shares of the company were exchanged, compared to its average volume of 4,190,717. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day moving average price of $555.25 and a two-hundred day moving average price of $562.50. The stock has a market cap of $500.51 billion, a price-to-earnings ratio of 35.43, a P/E/G ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period in the previous year, the business earned $6.56 EPS. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.54%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent analyst reports. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Monday, December 9th. UBS Group lowered their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Oppenheimer increased their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday. Finally, Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Two analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.